Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessio Innocenti

Showing results (11-20 of 140) with videos related to

Pageof 14
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 9, 2006
N-hydroxyurea--a versatile zinc binding function in the design of metalloenzyme inhibitorsClaudia Temperini, Alessio Innocenti, Andrea Scozzafava, et al.
Bioorganic & Medicinal Chemistry|June 27, 2008
Carbonic anhydrase inhibitors: inhibition of mammalian isoforms I-XIV with a series of substituted phenols including paracetamol and salicylic acidAlessio Innocenti, Daniela Vullo, Andrea Scozzafava, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2008
Carbonic anhydrase inhibitors: thioxolone versus sulfonamides for obtaining isozyme-selective inhibitors?Alessio Innocenti, Alfonso Maresca, Andrea Scozzafava, et al.
Bioorganic & Medicinal Chemistry Letters|February 12, 2009
Carbonic anhydrase inhibitors: two-prong versus mono-prong inhibitors of isoforms I, II, IX, and XII exemplified by photochromic cis-1,2-alpha-dithienylethene derivativesDaniel Vomasta, Alessio Innocenti, Burkhard König, et al.
Bioorganic & Medicinal Chemistry Letters|August 20, 2011
Phenylethynylbenzenesulfonamide regioisomers strongly and selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic isoforms I and IIEdward E Knaus, Alessio Innocenti, Andrea Scozzafava, et al.
Current Pharmaceutical Design|September 8, 2010
3-phenyl-1H-indole-5-sulfonamides: structure-based drug design of a promising class of carbonic anhydrase inhibitorsOzlen Güzel, Alessio Innocenti, Daniela Vullo, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2007
Carbonic anhydrase inhibitors. Interaction of the antiepileptic drug sulthiame with twelve mammalian isoforms: kinetic and X-ray crystallographic studiesClaudia Temperini, Alessio Innocenti, Antonio Mastrolorenzo, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivativesAlessio Innocenti, Jochen Antel, Michael Wurl, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2009
Carbonic anhydrase inhibitors. Phenacetyl-, pyridylacetyl- and thienylacetyl-substituted aromatic sulfonamides act as potent and selective isoform VII inhibitorsOzlen Güzel, Alessio Innocenti, Andrea Scozzafava, et al.
European Journal of Medicinal Chemistry|August 9, 2011
Carbonic anhydrase inhibitors. Synthesis, molecular structures, and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with novel 3-pyridinesulfonamide derivativesZdzisław Brzozowski, Jarosław Sławiński, Maria Gdaniec, et al.
Pageof 14

Showing results (11-20 of 140) with videos related to

Sort By:
Pageof 14
Bioorganic & Medicinal Chemistry Letters|June 9, 2006
N-hydroxyurea--a versatile zinc binding function in the design of metalloenzyme inhibitorsClaudia Temperini, Alessio Innocenti, Andrea Scozzafava, et al.
Bioorganic & Medicinal Chemistry|June 27, 2008
Carbonic anhydrase inhibitors: inhibition of mammalian isoforms I-XIV with a series of substituted phenols including paracetamol and salicylic acidAlessio Innocenti, Daniela Vullo, Andrea Scozzafava, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2008
Carbonic anhydrase inhibitors: thioxolone versus sulfonamides for obtaining isozyme-selective inhibitors?Alessio Innocenti, Alfonso Maresca, Andrea Scozzafava, et al.
Bioorganic & Medicinal Chemistry Letters|February 12, 2009
Carbonic anhydrase inhibitors: two-prong versus mono-prong inhibitors of isoforms I, II, IX, and XII exemplified by photochromic cis-1,2-alpha-dithienylethene derivativesDaniel Vomasta, Alessio Innocenti, Burkhard König, et al.
Bioorganic & Medicinal Chemistry Letters|August 20, 2011
Phenylethynylbenzenesulfonamide regioisomers strongly and selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic isoforms I and IIEdward E Knaus, Alessio Innocenti, Andrea Scozzafava, et al.
Current Pharmaceutical Design|September 8, 2010
3-phenyl-1H-indole-5-sulfonamides: structure-based drug design of a promising class of carbonic anhydrase inhibitorsOzlen Güzel, Alessio Innocenti, Daniela Vullo, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2007
Carbonic anhydrase inhibitors. Interaction of the antiepileptic drug sulthiame with twelve mammalian isoforms: kinetic and X-ray crystallographic studiesClaudia Temperini, Alessio Innocenti, Antonio Mastrolorenzo, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivativesAlessio Innocenti, Jochen Antel, Michael Wurl, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2009
Carbonic anhydrase inhibitors. Phenacetyl-, pyridylacetyl- and thienylacetyl-substituted aromatic sulfonamides act as potent and selective isoform VII inhibitorsOzlen Güzel, Alessio Innocenti, Andrea Scozzafava, et al.
European Journal of Medicinal Chemistry|August 9, 2011
Carbonic anhydrase inhibitors. Synthesis, molecular structures, and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with novel 3-pyridinesulfonamide derivativesZdzisław Brzozowski, Jarosław Sławiński, Maria Gdaniec, et al.
Pageof 14